secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jasper Therapeutics, Inc. (JSPR)
CIK:        0001788028
Form:       8-K
Filed at:   2026-10-07T12:05:39+00:00
Accession:  0001213900-26-107402
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Jasper Therapeutics offers $0.324 cash per warrant to retire 12,345,707 outstanding warrants, ~$4.0M max outlay
--------------------------------------------------------------------------------

- Tender offer at $0.324 in cash per warrant, without interest; warrants were issued in Jasper's September 18, 2025 underwritten public offering.
- 12,345,707 warrants were outstanding as of October 6, 2026; if all are tendered the company expects to pay about $4.0 million from cash on hand.
- Each warrant entitles the holder to buy one share of common stock at $2.92; tendered warrants are retired and cancelled rather than resold.
- Offer expires one minute after 11:59 p.m. ET on November 6, 2026, unless extended; tenders may be withdrawn any time before the deadline.
- Untendered warrants stay outstanding on original terms and expire at 5:00 p.m. ET on March 18, 2030; the offer has no minimum tender condition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1788028/000121390026107402/0001213900-26-107402-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1788028/000121390026107402/ea0307925-8k_jasper.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-107402

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer